$RDVT

Red Violet, Inc. (RDVT): Entry into a Material Definitive Agreement

Red Violet, Inc. (RDVT) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 red violet Announces Proposed Public Offering of Common Stock BOCA RATON, Fla., Aug. 05, 2026 (GLOBE NEWSWIRE) — Red Violet, Inc. (“red violet”) (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced the commencement of a proposed und

Original reporting
Published Aug 7, 2026, 8:20 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 8:22 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$RDVT
Neutral
medium confidence
Mentioned
$RDVT
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RDVTNeutralMed
01

Why it matters

The agreement signals an imminent or active equity offering process (firm and potential additional shares). Without pricing and proceeds details in the excerpt, the main tradable implication is dilution risk and capital-raising expectations.

02

Market read

A new equity issuance framework is disclosed via an underwriting agreement, which can drive near-term repricing due to dilution and funding narrative.

03

What to watch

Traders will need the final prospectus supplement for offering price, net proceeds, and use of funds to judge whether the equity raise is value-accretive or purely dilutive.

Relevance 6/10Novelty 8/10Timing: filed Aug 7, 2026, after-hours SEC 8-K

Background

The 8-K discloses Item 1.01, entry into a material definitive underwriting agreement, including a shelf registration statement on Form S-3.

Company-level read

Ticker impact

$RDVTNeutralMedium confidence
Context

Red Violet entered a material definitive underwriting agreement to issue and sell 1,666,667 firm shares plus up to 250,000 additional shares.

Expected impact

Near-term downside risk from dilution, with potential stabilization if proceeds are viewed as funding growth or reducing leverage.

Evidence & confidence

An 8-K underwriting agreement is a primary disclosure of an equity issuance size and mechanics, but the excerpt does not include pricing, proceeds, or use of funds, limiting precision on magnitude and direction.

Market effects

Adds to the broader small-cap growth equity issuance backdrop, potentially increasing sensitivity to dilution risk across similar issuers.

Primarily US small-cap sentiment, with limited direct regional spillover beyond US-listed peers.

Low global relevance; impact is mostly confined to US micro/small-cap capital markets sentiment.

Counterpoint

If the offering is priced attractively and tied to clear growth catalysts, the dilution overhang may be quickly absorbed.

Key entities

  • Red Violet, Inc.

    Company filing the 8-K and entering the underwriting agreement for a common stock offering.

  • Raymond James & Associates, Inc.

    Named as a representative of the underwriters in the underwriting agreement.

  • Needham & Company, LLC

    Named as a representative of the underwriters in the underwriting agreement.

Related articles

$RDVTMed

Red Violet, Inc. (RDVT): Results of Operations and Financial Condition

Red Violet, Inc. (RDVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 red violet Reports Second Quarter 2026 Financial Results Record Revenue of $26.7 Million, an Increase of 23%; Record Cash Flow from Operations of $10.6 Million BOCA RATON, Fla. – August 10, 2026 – Red Violet, Inc. (NASDAQ: RDVT), a leading identity intelligence and a

$RDVTMedAI 8/10

red violet Announces Closing of $115 Million Underwritten Public Offering of Common Stock, Including Full Exercise of Underwriters' Option

Red Violet, Inc. (NASDAQ: RDVT) said it closed an underwritten public offering of 1,916,667 shares of common stock, including 250,000 shares from full exercise of the underwriters’ option. The company estimates net proceeds of about $108.6 million. Proceeds will be used for working capital, general corporate purposes, and potential strategic acquisitions.

$RDVTMedAI 8/10

red violet Announces Pricing of $100 Million Underwritten Public Offering of Common Stock

Red Violet, Inc. (NASDAQ: RDVT) priced an underwritten public offering of 1,666,667 shares of common stock at $60.00 per share, raising expected gross proceeds of $100 million before underwriting fees and expenses. The offering is expected to close Aug. 7, 2026, with a 30-day option for up to 250,000 additional shares. Net proceeds will fund working capital and corporate purposes.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Corporate Presentation - Outlines Growth Strategy for North American Lithium Platform

Elevra Lithium Ltd (ASX:ELV) outlined its growth strategy for North American Lithium (NAL) in Quebec, targeting 373,000 tonnes of spodumene concentrate annually. FY26 production was 197,967 tonnes, with revenue of US$202 million. The company plans a three-stage expansion, with initial capital expenditure of US$271 million. FY27 production guidance is 198,000 to 210,000 tonnes.